Monday, September 24, 2012

Focus

Virasep is a franchise 'incubator' biotechnology business engaged in viral purification for human gene therapy applications specializing in **adeno virus (BSL2!), **~#adeno-associated virus (BSL1), >retrovirus [family: retroviridae] (BSL2!), *~+herpes simplex virus (BSL2!), and >>~&lentivirus (BSL2!) (hiv,siv,fiv). The annual franchise fee is USA $6,000 payable by December 25. This website is available for sale (USA $500,000) or licensing (USA $50,000/year). For additional information please contact: Mr.Somesh R. Doddi, CEO/Chief Scientist, sdoddi11@hotmail.com, Cell: +91-9773033833. Thank You.